Why Attend: Driving the Future of Ocular Drug Delivery: Insights from the 4th Ophthalmic Drug Delivery Summit
In the fast-evolving field of ophthalmology, staying ahead means more than keeping up with the latest research. It means connecting with the innovators shaping the future of targeted, sustained, and patient-centric ocular therapies. The 4th Ophthalmic Drug Delivery Summit offers exactly that opportunity.
Why Ocular Drug Delivery Innovation Matters
Advances in therapies for retinal disease, glaucoma, and other ocular conditions have highlighted the need for smarter, sustained-release delivery systems. Whether it’s long-acting biologics, refillable implants, or device-enabled platforms, innovative delivery strategies are critical to improving patient outcomes, reducing dosing burden, and accelerating time to clinic.
What You’ll Gain at the Summit
Attendees will hear directly from over 20 industry leaders from companies such as Genentech, AbbVie, Johnson & Johnson, Novartis and Boehringer Ingelheim.
Sessions will cover cutting-edge approaches in ocular drug delivery, including:
Long-acting biologics and device-enabled delivery for improved therapeutic efficacy
Strategies to accelerate translation from discovery to clinic, tackling challenges like ocular pharmacokinetics, formulation stability, and regulatory alignment
Real-world case studies from Ripple Therapeutics, Clearside Biomedical, and others, offering actionable insights for glaucoma, retinal detachment, and other retinal diseases
High-value networking with senior pharma, biotech, and academic leaders to foster collaboration and innovation
Benchmark, Learn, and Innovate
The summit is a chance to benchmark your work against leaders in ophthalmic drug delivery, discover emerging technologies, and walk away with a practical roadmap to de-risk development and accelerate patient access to new therapies.
For professionals driving innovation in ophthalmology, attending the 4th Ophthalmic Drug Delivery Summit is an investment in knowledge, connections, and the future of eye care.
Register now to secure your spot and connect with retina pioneers and drug delivery experts.
Explore the Full Event Guide
- 3 days of cutting-edge ophthalmic drug delivery content
- 3 interactive pre-conference workshops
- Long-acting, gene & cell therapy, topical, implantable & suprachoroidal delivery
- Insights from leaders at Eli Lilly, Genentech, Sanofi, Astellas & more
- Speed networking, roundtables, panels and poster sessions designed for meaningful industry connection
Explore The Latest Delivery Innovations
See how long acting, suprachoroidal, implantable and topical technologies are changing the possibilities for ocular therapy to identify approaches that could improve durability, efficacy and patient outcomes.
Meet Experts Shaping the Field
Connect with the scientists, clinicians, developers and technology leaders solving the industry's toughest delivery challenges to build relationships that can accelerate your next program.
Move Your Program Forward
Take practical insights from toxicology and translation through to regulatory, manufacturing and clinical development, helping you de-risk development and accelerate your path to the clinic .